NKAP Antikörper (C-Term)
Kurzübersicht für NKAP Antikörper (C-Term) (ABIN7467845)
Target
Alle NKAP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the C-terminus region of human NKAP. The exact sequence is proprietary.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- ICC/IF: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.01 mg/mL
-
Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- NKAP (NFKB Activating Protein (NKAP))
-
Andere Bezeichnung
- NFKB activating protein
-
Hintergrund
- NFKB activating protein,NKAP is a transcriptional repressor that associates with the NOTCH (see MIM 190198) corepressor complex and is required for T-cell development (Pajerowski et al., 2009 [PubMed 19409814]).[supplied by OMIM]
-
Molekulargewicht
- 47 kDa
-
Gen-ID
- 79576
-
UniProt
- Q8N5F7
-
Pathways
- Stem Cell Maintenance, Phosphorylierungen bei SARS-CoV-2 Infektion
Target
-